Who owns ACASTI PHARMA INC?

Tip: Access positions for across all investors

Analyze quarterly positions in Acasti Pharma with up to 7 years of data, all consolidated into one spreadsheet

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Top investors of Acasti Pharma stock

Who bought or sold ACASTI PHARMA INC this quarter?

Fund or Company Name Shares Held Valued At Change in Shares As Of Actions
Nantahala Capital Management 1.2M $4.1M 0% Dec 2025
 View chart
AIGH Capital Management 907k $3.2M 0% Dec 2025
 View chart
ADAR1 Capital Management 642k $2.2M 83% Dec 2025
 View chart
Vanguard Group 424k $1.5M 4% Dec 2025
 View chart
HPM Partners 423k $1.5M 100% Dec 2025
 View chart
Renaissance Technologies 130k $449k 53% Dec 2025
 View chart
XTX Topco 30k $106k 100% Dec 2025
 View chart
Citadel Advisors 27k $81k -21% Sep 2025
 View chart
GSA Capital Partners 14k $48k 100% Dec 2025
 View chart
Stratos Wealth Partners 11k $39k 100% Dec 2025
 View chart
National Bank Of Canada /fi/ 2.7k $9.4k 0% Dec 2025
 View chart
Tower Research Capital 1.9k $6.7k 21% Dec 2025
 View chart
Bnp Paribas Arbitrage, Snc 600.00 $2.1k 100% Dec 2025
 View chart
Royal Bank of Canada 571.00 $2.1k 5% Sep 2025
 View chart
Activest Wealth Management 104.00 $359.996000 0% Dec 2025
 View chart
SBI Securities 101.00 $348.995400 0% Dec 2025
 View chart
Steward Partners Investment Advisory 41.00 $141.999400 0% Dec 2025
 View chart
Flagship Harbor Advisors 2.00 $7.000000 100% Dec 2025
 View chart
Nbc Securities 2.00 $6.000000 0% Dec 2025
 View chart
Federation des caisses Desjardins du Quebec 1.00 $3.000000 0% Dec 2025
 View chart

Who sold out of Acasti Pharma?

Fund or Company Name Date Sold Shares Held Valued At
Stonepine Capital Management Sep 2025 211k $628k
Millington Financial Advisors Sep 2025 20k $60k
SeaCrest Wealth Management Sep 2025 14k $42k